Health technologies are reshaping healthcare, opening up new ways to care for patients, diagnose conditions earlier, and help people stay healthier for longer. From wearables to A ...

NICE is currently consulting on updated evaluation methods through October 2025, working with industry and healthcare partners to refine the assessment framework. The programme will initially focus on ...

This guidance has been updated and replaced by NICE technology appraisal guidance 939 ...

This guideline covers the diagnosis and management of obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS) and chronic obstructive pulmonary disease with OSAHS ...

NICE has been working in partnership with the London School of Economics and Political Science (LSE) to jointly develop and deliver an Executive MSc in Healthcare Decision-Making. Discover how this ...

NICE is unable to make a recommendation on mirabegron (Betmiga) for treating neurogenic detrusor activity in people 3 to 17 years. This is because the company did not provide an evidence submission.

Adults diagnosed with a functional neurological disorder are supported to manage symptoms that are a part of the disorder in non-specialist care. Adults with symptoms that occur as part of a ...

Healthcare professionals do not use scoring tools to identify which adults with osteoarthritis are eligible for referral for consideration of joint surgery. Evidence for the Oxford Hip and Knee scores ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

DMD Care UK's guideline on cardiac care of children with dystrophinopathy and females carrying DMD-gene variations: NICE review NG251 5 September 2025 5 September 2025 ...

This is the user guide for submission of evidence to the National Institute for Health and Care Excellence (NICE) as part of the single technology appraisal and highly specialised technologies ...

These recommendations are for healthcare professionals providing care for people with ongoing symptomatic COVID-19 or post-COVID-19 syndrome in primary care and community settings or in ...